Plushcare Weight Loss Review: Insurance-First GLP-1 Prescriptions (May 2026)

You have commercial insurance, you've confirmed your plan covers Wegovy or Zepbound, and you need a telehealth prescriber. You are not looking for a lifestyle coach or a compounding pharmacy. You want a licensed doctor to write the prescription, handle the prior authorisation, and get out of your way. That is the specific situation in which Plushcare earns its place on this site.

Plushcare is not a weight-loss telehealth specialist in the mould of Henry Meds or Calibrate. It is a primary-care telehealth platform — one of the largest in the country, now owned by Accolade — that offers GLP-1 prescriptions as part of a broad primary-care membership. This review explains what that distinction means in practice, what the real costs are, and where the model falls short.

About this review: Built from Plushcare’s published programme and pricing materials, third-party reviews, and public patient accounts. A full hands-on sign-up review is pending. Corrections: [email protected]

Plushcare at a glance

What Plushcare is, and is not, for GLP-1s

Plushcare is a primary-care telehealth service. You pay a monthly membership, book video appointments with board-certified MDs, and get care across the primary-care spectrum — UTIs, blood pressure management, chronic disease, GLP-1 prescriptions. GLP-1 prescriptions are one service on a long menu, not the product.

This matters because the GLP-1 telehealth market has two distinct categories:

Dedicated weight-management platforms (Mochi, Calibrate, Form Health) build their entire clinical infrastructure around obesity medicine: structured titration protocols, PA-navigation workflows, metabolic lab tracking, lifestyle coaching. When they say they handle prior authorisation, it is a core programme feature with dedicated staff.

Primary-care platforms (Plushcare) can prescribe GLP-1s, but they do it inside a general primary-care visit. The prescriber writes the PA documentation; the care team follows up. The support is real but it is not the product — it is one task among many.

Neither model is inherently better. The question is fit. Plushcare is the right fit for patients who need a prescriber, not a programme.

Pricing reality: insured vs cash-pay

With commercial insurance covering GLP-1s

This is Plushcare’s home territory. If your plan covers Wegovy or Zepbound, here is the realistic monthly out-of-pocket:

That total is lower than most dedicated weight-management telehealth platforms, whose memberships alone run $99–$199/month before drug costs. The downside is fewer programme features — no structured coaching, no habit tracking, no metabolic curriculum.

Without insurance coverage

Here the calculus shifts sharply:

The drug cost is the dominant number, and it is the same whether you use Plushcare or any other prescriber. Getting a cheaper prescriber relationship ($0–$99/month at services like HealthTap or through your own PCP) and going to NovoCare direct is often more cost-efficient for cash-pay patients than routing through Plushcare.

Important note: Plushcare does not offer a compounded GLP-1 programme. If your insurance denies coverage and branded drug prices are prohibitive, Plushcare’s own GLP-1 page mentions compounded semaglutide as an outside option — but Plushcare cannot prescribe it through their platform. You would need a separate provider for that path.

The insurance path: when Plushcare makes sense

Plushcare is in-network with over 100 commercial insurance plans including Aetna, Cigna, UnitedHealthcare, Anthem, and Humana. Visits are billed as primary-care consultations, which means the visit cost runs through your medical benefit, not a separate telehealth rider.

GLP-1 prescriptions typically require prior authorisation. Plushcare’s physicians and care team manage that process: they submit documentation, respond to insurer requests for clinical information, and — if the initial PA is denied — can conduct peer-to-peer calls between the Plushcare physician and the insurance company’s medical director. That peer-to-peer capability is a meaningful differentiator; many telehealth platforms do not offer it.

The PA process typically takes 7–14 days from submission. Plushcare publishes common denial reasons — plan exclusion for weight loss, non-formulary status, step-therapy requirements — and their care team can advise on documentation that strengthens the submission.

When Plushcare makes sense for insurance:

• Your plan covers Wegovy or Zepbound for obesity (BMI ≥30, or ≥27 with comorbidity)
• Your clinical picture is straightforward — you have the qualifying diagnosis documented, you can satisfy step-therapy requirements if needed
• You want a synchronous doctor relationship, not asynchronous messaging

When you may want a more specialist platform:

• Your plan has a complex formulary with non-preferred tier requirements and step-therapy
• You have already had one denial and need intensive PA advocacy (repeated appeals, external review)
• You want a clinician whose daily practice is obesity medicine rather than general primary care

Sign-up and intake experience

Plushcare’s intake follows a standard telehealth pattern: create an account, provide insurance information, answer a brief health questionnaire, book an appointment. Same-day slots are available seven days a week — multiple third-party reviewers and Plushcare’s own marketing note that appointments are often available within 30 minutes of booking.

Visits are synchronous video consultations, approximately 15 minutes, with a board-certified MD. Plushcare advertises board-certified M.D.s across its network rather than nurse practitioners, which is a point of differentiation from some competitors. After the visit, if the clinician determines a GLP-1 is appropriate, they issue the prescription and initiate the PA process if needed.

A note on quality consistency: Plushcare has a large provider network. Patient accounts vary — some report engaged, thorough consultations; others describe rushed 5-minute interactions. This is an inherent feature of a large network telehealth platform. If your first appointment feels rushed, booking with a different provider is an option.

PA support: honest assessment

Plushcare’s PA support is real and more substantive than the average primary-care telehealth platform. The physician-led peer-to-peer call capability is particularly valuable. A Reddit user navigating a complex Zepbound PA (PCOS, prior Wegovy intolerance, step-therapy requirement) noted Plushcare as an option for GLP-1-friendly telehealth doctors who know how to submit strong PA requests — which is a genuine reputation signal.

However, PA navigation at Plushcare is a support service, not the product. The platform does not publish specific PA approval rates, does not have a dedicated PA-navigation team in the way Mochi or Calibrate do, and the quality of PA support varies with the individual physician you see.

If your situation is a first-time PA on a plan that commonly covers GLP-1s, Plushcare is likely adequate. If you are on a second or third appeal, or your plan has an unusual formulary structure, a weight-management-specialist platform with dedicated PA infrastructure may serve you better.

What patients report: support quality and billing

Plushcare’s Trustpilot score sits at 3.4/5 across more than 2,600 reviews. The pattern in public accounts breaks along a consistent fault line:

Positive signals:

• Physician quality and professionalism generally rated well
• Same-day availability appreciated, especially by self-employed patients without PCP access
• Patients with straightforward insured GLP-1 prescriptions report smooth experiences
• The $19.99 membership fee is cited as a fair price for ongoing access

Negative patterns:

• Billing opacity is the dominant complaint. The membership, visit fees, labs, and medication are billed separately and through different payment channels (membership on card; visit through insurance; drug through pharmacy benefit). Patients report confusion and unexpected charges.
• Auto-renewal practices drew a class action lawsuit (Robbins v. PlushCare Inc., filed 2021, settled by October 2023). The lawsuit alleged PlushCare automatically enrolled patients in monthly subscriptions during appointment booking without clear disclosure. The settlement was distributed to class members; Plushcare has updated its disclosure practices, but auto-renewal warnings remain common in recent patient accounts.
• Customer service responsiveness for billing disputes is rated poorly across BBB and Trustpilot. Plushcare has a 2.09/5 BBB rating, primarily driven by billing and cancellation complaints.

The pattern is clear: Plushcare’s clinical model works; its billing infrastructure generates friction. Going in with eyes open on the membership auto-renewal and the separated billing streams reduces the risk of an unpleasant surprise.

Cancellation: how to do it cleanly

Cancellation is self-serve through the account portal:

1. Log into your Plushcare account
2. Navigate to your profile → Payment and Insurance tab
3. Click "cancel your membership"
4. Complete the cancellation prompts

Cancel at least one calendar day before your renewal date to avoid being charged for the next cycle. Refunds are not issued for partial periods. If you cannot complete cancellation online, email [email protected] or call customer support.

Your clinical records are yours under HIPAA. If you are switching providers, you can request your records and have your current prescription transferred to another prescriber or pharmacy.

Practical advice: Given the auto-renewal history, set a phone calendar reminder the week before your expected renewal date as a backup. Do not rely on email billing notices alone.

Best for / Not for

Plushcare is best for:

• Patients with commercial insurance that covers Wegovy or Zepbound
• Patients who want a low-cost monthly prescriber relationship ($19.99) rather than a full weight-management programme
• Patients who want synchronous video visits with board-certified MDs
• Patients whose PA situation is straightforward (first-time submission, qualifying diagnosis clearly documented)
• Patients who already use or want Plushcare for broader primary care

Plushcare is not ideal for:

• Cash-pay patients — the branded drug cost is the same regardless of prescriber; cheaper prescribers exist
• Patients who need intensive PA navigation (multiple appeals, step-therapy bypass, complex comorbidity documentation)
• Patients who want lifestyle coaching, nutrition support, or structured weight-management programming
• Patients who want compounded GLP-1s at a lower price point
• Patients who need Medicare or Medicaid GLP-1 coverage

Plushcare vs Mochi: the insurance-first vs hybrid comparison

The bottom line: If your insurance covers GLP-1s and your clinical picture is uncomplicated, Plushcare saves you $80–$140/month in membership fees compared to Mochi with no meaningful loss in prescription access. If you need intensive PA support, a structured clinical programme, or a cash-pay compounding path, Mochi is the stronger platform.

For the full provider landscape, see our provider comparison page.

Frequently asked questions

Does Plushcare prescribe Wegovy, Ozempic, Zepbound, and Mounjaro? Yes to all four, plus Saxenda, Rybelsus, Victoza, and other FDA-approved options. Plushcare prescribes seven or more brand-name GLP-1 and weight-related medications — more options than most dedicated weight-loss platforms.

How long does it take to get a GLP-1 prescription through Plushcare? The initial consultation is often available same-day. If no PA is needed (rare for GLP-1s), the prescription can be sent the same day. With PA, expect 7–14 days for insurer review. Complex cases or appeals add time.

Does Plushcare use nurse practitioners or MDs? Plushcare advertises board-certified MDs across its network, in contrast to some competitors that use nurse practitioners or physician assistants as the primary prescriber.

Can I use FSA or HSA funds for Plushcare? Yes. Plushcare accepts FSA and HSA cards for eligible medical expenses including visit fees and prescription costs.

What happens if my prior authorisation is denied? Plushcare’s care team can appeal the denial and, if needed, arrange a peer-to-peer call between your physician and the insurance company’s medical director. If the appeal fails, you have three options: pay cash for the branded drug (at NovoCare/LillyDirect prices), request a formulary exception, or pursue an external review. Plushcare’s own GLP-1 page mentions compounded semaglutide as an outside cash-pay option if all insurance paths fail.

Is there a free trial for Plushcare? Plushcare offers a first month free on the membership. Visit fees and drug costs are separate and not covered by the trial.

Is Plushcare legit? Yes. Plushcare is a licensed telehealth company, part of a publicly traded corporation (Accolade, NASDAQ: ACCD). It employs board-certified MDs and operates within standard telehealth regulatory frameworks. The billing and auto-renewal complaints are real, but they are operational issues with a real and functioning platform, not indicators of a scam.

How does Plushcare compare to going directly to NovoCare? NovoCare (Novo Nordisk’s direct pharmacy programme) requires a prescription from any licensed provider. If you already have a prescriber — your own PCP or a low-cost telehealth service — you do not need Plushcare to access NovoCare pricing. Plushcare’s value is the prescriber relationship and PA support, not any drug pricing advantage. For cash-pay cost context, see cheapest place to get Wegovy.

This review is built from public sources including Plushcare’s published programme materials, third-party published reviews, and public patient accounts. It is an editorial-only review — clinical-care scoring is deferred to the phase following MD reviewer onboarding. If you spot an error or a pricing change, email [email protected]. This page is updated monthly.